LEVI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 630
EU - Europa 358
AS - Asia 108
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 1.107
Nazione #
US - Stati Uniti d'America 627
IT - Italia 167
FI - Finlandia 45
SG - Singapore 37
IE - Irlanda 31
DE - Germania 26
CN - Cina 25
HK - Hong Kong 24
GB - Regno Unito 20
SE - Svezia 18
BE - Belgio 15
UA - Ucraina 12
PL - Polonia 10
FR - Francia 6
IN - India 6
MK - Macedonia 4
CA - Canada 3
CY - Cipro 3
MY - Malesia 3
NA - Namibia 3
VN - Vietnam 3
AU - Australia 2
EU - Europa 2
OM - Oman 2
TR - Turchia 2
BR - Brasile 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IR - Iran 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 1.107
Città #
Chandler 114
Ashburn 98
Brescia 61
New York 46
Helsinki 43
Princeton 42
Fairfield 38
Seattle 28
Woodbridge 28
Hong Kong 24
Verona 24
Wilmington 24
Cambridge 22
Dublin 22
Houston 18
Brussels 15
Shanghai 13
Singapore 13
Ann Arbor 12
Washington 12
Beijing 11
Jacksonville 10
Los Angeles 10
Trento 10
Warsaw 10
Cazzago San Martino 6
Des Moines 5
Gunzenhausen 5
Rome 5
San Francisco 5
Islington 4
London 4
Piangipane 4
Pune 4
San Diego 4
Skopje 4
Dong Ket 3
Kuala Lumpur 3
Windhoek 3
Council Bluffs 2
Cremona 2
Ferrara 2
Kilburn 2
Lappeenranta 2
Monmouth Junction 2
New Bedfont 2
Seeb 2
Strasbourg 2
Toronto 2
Villafranca d'Asti 2
Abbiategrasso 1
Acton 1
Borås 1
Botticino 1
Braunschweig 1
Canberra 1
Chicago 1
Clifton 1
Falkenstein 1
Hangzhou 1
Hounslow 1
Kish 1
Kocaeli 1
Menlo Park 1
Milano 1
Modena 1
Montreal 1
Mortara 1
Mumbai 1
Munich 1
Napoli 1
New Delhi 1
Nicosia 1
Norwalk 1
Paris 1
Patras 1
Riyadh 1
Rockville 1
Rovereto 1
Santa Clara 1
Surabaya 1
Sydney 1
São Paulo 1
Tanta 1
Totale 863
Nome #
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 97
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 92
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 65
Consequences of SARS-COV-2 Pneumonia on Lung function 65
Phenotyping OSAH patients during wakefulness 64
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 63
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 62
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 55
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 53
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 50
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 49
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 46
EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA 45
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 45
A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia 44
Ultrasonographic Evaluation of Subglottic Stenoses: A Preliminary Analysis 41
Quantification of circulating alpha-1-antitrypsin polymers in dried blood spots 39
PHENOTYPING PATIENTS WITH OSAH DURING WAKEFULNESS 36
Evaluating the Respiratory Function Impairments in Patients with Previous SARS-COV2 Pneumonia 35
Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study 35
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 33
Simplified Daytime Approach in OSAH Phenotyping 25
Pulmonary rehabilitation improves functional outcomes and quality of life in post-SARS-CoV-2 mild-to-moderate infection patients: a pilot study 25
Totale 1.164
Categoria #
all - tutte 8.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021270 18 5 13 26 48 26 14 26 14 23 41 16
2021/2022235 10 17 9 14 3 27 23 18 19 22 25 48
2022/2023324 33 43 16 25 15 61 0 55 29 1 15 31
2023/2024323 20 2 31 51 11 94 3 36 35 6 6 28
2024/202512 5 7 0 0 0 0 0 0 0 0 0 0
Totale 1.164